Humanized Antibodies as Potential Therapeutic Drugs
Open Access
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 81 (2), 105-119
- https://doi.org/10.1016/s1081-1206(10)62794-9
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Bispecific HER2 × CD3 Antibodies Enhance T-Cell Cytotoxicity in Vitro and Localize to HER2-Overexpressing Xenografts in Nude MiceClinical Immunology and Immunopathology, 1995
- Treatment of Rheumatoid Arthritis with a Chimeric CD4 Monoclonal Antibody (cM‐T412): Immunopharmacological Aspects and Mechanisms of ActionScandinavian Journal of Immunology, 1994
- Safety and efficacy of therapeutic monoclonal antibodies in clinical therapyImmunology Today, 1993
- The IL-2/IL-2 receptor system: a target for rational immune interventionImmunology Today, 1993
- A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding propertiesMolecular Immunology, 1991
- Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomasJournal of the American Academy of Dermatology, 1989
- Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to AllergensNew England Journal of Medicine, 1989
- Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration.Journal of Clinical Investigation, 1988
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986
- A hapten-specific chimaeric IgE antibody with human physiological effector functionNature, 1985